{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19454445",
  "DateCompleted": {
    "Year": "2010",
    "Month": "03",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1093/annonc/mdp163"
    ],
    "Journal": {
      "ISSN": "1569-8041",
      "JournalIssue": {
        "Volume": "20 Suppl 4",
        "PubDate": {
          "Year": "2009",
          "Month": "May"
        }
      },
      "Title": "Annals of oncology : official journal of the European Society for Medical Oncology",
      "ISOAbbreviation": "Ann Oncol"
    },
    "ArticleTitle": "Management of febrile neutropenia: ESMO clinical recommendations.",
    "Pagination": {
      "StartPage": "166",
      "EndPage": "169",
      "MedlinePgn": "166-9"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medical Oncology, University Hospital Birmingham, NHS Foundation Trust, Birmingham, UK."
          }
        ],
        "LastName": "Marti",
        "ForeName": "F Marti",
        "Initials": "FM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cullen",
        "ForeName": "M H",
        "Initials": "MH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Roila",
        "ForeName": "F",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "CollectiveName": "ESMO Guidelines Working Group"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Ann Oncol",
    "NlmUniqueID": "9007735",
    "ISSNLinking": "0923-7534"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Management"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Europe"
    },
    {
      "QualifierName": [
        "chemically induced",
        "therapy"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Planning Guidelines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "chemically induced",
        "therapy"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [
        "standards"
      ],
      "DescriptorName": "Societies, Medical"
    }
  ],
  "NumberOfReferences": "10"
}